Cimivir – L




Product Details:

Minimum Order Quantity 3 Bottle
Brand Biocon


  • Treating chronic hepatitis C virus (HCV) infection in certain patients.Cimivir L (Ledipasvir Sofosbuvir) is a combination of 2 hepatitis C virus (HCV) antiviral agents.
  • It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.

Mechanism of action:

  • Ledipasvir is a potent inhibitor of HCV NS5A, a viral phosphoprotein that plays an important role in viral replication, assembly, and secretion.
  • Sofosbuvir is a nucleotide analog inhibitor of hepatitis C virus NS5B polymerase—the key enzyme mediating HCV RNA replication. The triphosphate form of sofosbuvir (GS-461203) mimics the natural cellular uridine nucleotide and is incorporated by the HCV RNA polymerase into the elongating RNA primer strand, resulting in viral chain termination.
  • Dosage and Administration:Cimivir L (Ledipasvir Sofosbuvir) (90 mg/400 mg) is a fixed-dose combination tablet .
  • The recommended dosage is one tablet once daily, with or without food.


  • Tell your doctor or dentist that you take Cimivir L (Ledipasvir Sofosbuvir) before you receive any medical or dental care, emergency care, or surgery.·
  • Do not share needles, injection supplies, or items like toothbrushes or razors.
  • Talk with your health care provider about ways to prevent the spread of HCV to others.


  • Cimivir L (Ledipasvir Sofosbuvir) room temperature away from moisture and heat.


There are no reviews yet.

Be the first to review “Cimivir – L”

Your email address will not be published. Required fields are marked *